Gene Therapy Market Global Forecast to 2032: Biopharma Giants Lead Gene Therapy Market Expansion – Latest Developments & Projections
The global gene therapy market is projected to grow from $8.85 billion in 2024 to $36.55 billion by 2032, at a CAGR of 19.4%.
News-Medical.Net3d
Could CRISPR Help Prevent the Next Global Pandemic?
CRISPR technology offers innovative solutions for pandemic preparedness, enhancing diagnostics, antiviral therapies, and ...
XPOVIO Continues to Disrupt the Oncology Market with Expanded Indications and Strong Market Performance | DelveInsight
DelveInsight's "XPOVIO Market Size, Forecast, and Market Insight Report" highlights the details around XPOVIO, a ...
News-Medical.Net4d
New CRISPR-enriched metagenomics method or detecting antibiotic resistance genes in wastewater
Antibiotic resistance is a global concern that threatens our ability to prevent and treat bacterial infections in humans and animals.
Genomic Reference Materials and Controls Systems Market, 2025-2035 - Companies Set to Capitalize on Liquid Biopsy and MRD Testing Demand
The "Genomic Reference Materials and Controls Systems Market: Focus on Product Type, Application, End User, and Country-Level Analysis - Analysis and Forecast, 2025-2035" report has been added to ...
Global In Situ Hybridization Market to Grow at a CAGR of ~7% by 2032 | DelveInsight
DelveInsight's In Situ Hybridization Market Insights report provides the current and forecast market analysis, individual ...
Le Lézard11d
CRISPR Market is expected to generate a revenue of USD 12.78 Billion by 2032, Globally, at 15.85% CAGR: Verified Market Research®
LEWES, Del., Feb. 26, 2025 /PRNewswire/ -- The Global CRISPR Market Size is projected to grow at a CAGR of 15.85% from 2026 to 2032, according to a new report published by Verified Market Research®.
Creative Bloq on MSN13d
From Apple to Nike, I’m mesmerised by these hypnotising chrome logos
Inspired by Apple's latest event invites, design company Paper has created a slick new tool that turns logos into hypnotic ...
Business Insider19d
Crispr Therapeutics price target lowered to $82 from $89 at Citi
Citi analyst Yigal Nochomovitz lowered the firm’s price target on Crispr Therapeutics (CRSP) to $82 from $89 and keeps a Buy rating on the shares. While Casgevy is making progress based on 2024 ...